Combivir
Product Images NDC 21695-846

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Combivir (NDC 21695-846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lamivudine Chemical Structure (D8540843 055c 47fb 9cff 81e64b1d41c3 01)

Chemical structure of the active ingredient in COMBIVIR, showing a nucleoside analog with a pyrimidine base and a five-membered sugar ring containing sulfur and hydroxyl groups.*

FDA Label Image

Zidovudine Chemical Structure (D8540843 055c 47fb 9cff 81e64b1d41c3 02)

Chemical structure of the active ingredient in COMBIVIR, depicting a nucleoside analog with azido and hydroxymethyl functional groups attached to the sugar ring and a methylated pyrimidine base.*

FDA Label Image

Combivir 150mg/300mg (D8540843 055c 47fb 9cff 81e64b1d41c3 03)

Combivir 150mg/300mg tablets packaging label from Physician Partner, distributed by Rebel Distributors Corp. Label states each tablet contains 150mg Lamivudine and 300mg Zidovudine. Includes product ID PC084606 and notes labeler GlaxoSmithKline Research, Triangle Park, NC. Storage instructions advise controlled temperature of 15-30°C (59-86°F) and keeping medication out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.